Daniel Lorrain
Förmögenhet: 2 M $ per 2026-08-31
Förmögenhet: 2 M $ per 2026-08-31
Daniel S.
Lorrain is the founder of Contineum Therapeutics, Inc., founded in 2017, serving as Chief Scientific Officer since 2018.
Former jobs include Senior Director at Amira Pharmaceuticals, Inc. from 2005 to 2010, and Vice President-Biology at Inception Sciences, Inc. from 2016 to 2018.
Education includes an undergraduate degree conferred in 1991 and a doctorate conferred in 1997, both from the State University of New York at Buffalo.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-09 | 145 312 ( 0,44 % ) | 2 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Grundare | 2017-05-09 |
| Företag | Position | Slut |
|---|---|---|
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Direktör/Styrelseledamot | 2018-01-10 |
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Direktör/Styrelseledamot | 2010-11-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån